Perioperative morbidity and mortality associated with vitreoretinal and ocular oncologic surgery performed under general anesthesia.
Perioperative morbidity and mortality associated with vitreoretinal and ocular oncologic surgery performed under general anesthesia.
复制标题
与全身麻醉下进行的玻璃体视网膜和眼部肿瘤手术相关的围手术期发病率和死亡率。
DOI:
--
复制
发表时间:
2003
期刊:
影响因子:
--
通讯作者:
D. Robertson
中科院分区:
文献类型:
--
作者:
C. McCannel;J. Nordlund;D. Bacon;D. Robertson
PURPOSE
To determine the incidence of postoperative systemic complications and nonophthalmic reasons for prolonged hospitalization after vitreoretinal procedures performed under general anesthesia.
METHODS
Patient charts of vitreoretinal or ocular oncologic surgical cases performed under general anesthesia between 1996 and 2001 were reviewed retrospectively. Occurrences of postoperative systemic events within 4 weeks of surgery were documented.
RESULTS
We identified 418 cases as having been performed under general anesthesia during the study period. The mean American Society of Anesthesiology physical status classification was 2.1. There were no confirmed cases of myocardial infarction (MI), pulmonary embolism (PE), or deep venous thrombosis (DVT) within the first 24 hours after surgery. There were two instances of hospital admission for evaluation of postoperative chest pain (0.48%; 95% CI, 0.06-1.72), and four instances of hospital admission, or prolongation of stay, because of urinary retention (0.96%; 95% CI, 0.26-2.43). In the 4 weeks following surgery, there was one MI (0.24%; 95% CI, 0.01-1.33), 2 cases of nonfatal PE (0.48%; 95% CI, 0.06-1.72), and 2 cases of DVT (0.48%; 95% CI, 0.06-1.72). All patients that developed PE and DVT had risk factors for the development of thromboembolic disease in addition to surgery under general anesthesia.
CONCLUSIONS
In this study, 2.6% of cases had postoperative systemic complications after vitreoretinal or ocular oncologic surgery that was conducted under general anesthesia. Urinary retention was the most common reason for unanticipated hospital stay.